Although NRF2 knockdown did not directly alter LPS-induced F3 expression (previously shown in Supplementary Fig. 2c), NRF2 activation by 4-OI may contribute to decreased type I IFN signaling40,69 by an as-yet-unknown mechanism and therefore decrease coagulopathy in COVID-19. This evidence concerns the gene NFE2L2 and COVID-19.